Corbus Pharmaceuticals Holdings (CRBP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Corbus Pharmaceuticals Holdings (CRBP) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.00 of bullish evidence against -0.36 bearish.

Corbus Pharmaceuticals Holdings last closed at $5.38, +2.09% on the session.

Against the IVW growth benchmark the position is +1.29% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for CRBP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Corbus Pharmaceuticals Holdings in the 12th percentile on return on equity, where 100 is best.

Corbus Pharmaceuticals Holdings is classified under Health Care / Biotechnology, with a market capitalisation of $101.93M.

StockMap tracks Corbus Pharmaceuticals Holdings as the 283rd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Corbus Pharmaceuticals Holdings ranks 342nd of 381 in the group, against a group median of -0.08.